Kynmobi - Drug Details
๐Ÿ“Š Estimates Kynmobi Dialyzability By Different_Modalities

Kynmobi

Complete Drug Information

Drug Name
Kynmobi
Trade Names
Apokyn, Kynmobi
Pregnancy Category
AU: B3
Bioavailability
100% following injection
Routes of Administration
Subcutaneous, sublingual
Protein Binding
~50%%
Metabolism
Liver, phase II
Elimination
40 minutes
Excretion
Liver
Formula
C17H17NO2
Molar Mass
267.328
Onset of Action
10โ€“20 min
Duration of Action
60โ€“90 min
Volume of Distribution
C17H17NO2

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.